EUVIMEDEUVIMED entdecken
Crossref

Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia

Serdar İleri, Orhan Ayyıldız

Eurasian Journal of Medical Advances · 2026 · 39-45

DOI: 10.14744/ejma.260346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medical Advances, 2026. Verfasst von Serdar İleri und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Eurasian Journal of Medical Advances (EJMA) is an open access, double-blind peer-reviewed medical journal publishing qualified research across all medical investigations. The journal is published quarterly in March, June, September and December.

Zitieren

APA

İleri, S., & Ayyıldız, O. (2026). Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia. Eurasian Journal of Medical Advances, 39-45. https://doi.org/10.14744/ejma.260346

Vancouver

İleri S, Ayyıldız O. Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia. Eurasian Journal of Medical Advances. 2026:39-45. doi:10.14744/ejma.260346

BibTeX
@article{leri2026,
  author = {İleri, Serdar and Ayyıldız, Orhan},
  title = {Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia},
  journal = {Eurasian Journal of Medical Advances},
  year = {2026},
  pages = {39--45},
  doi = {10.14744/ejma.260346}
}
Kostenlos starten →